PCOS Rebranded as PMOS: A New Era of Care

Polycystic ovary syndrome, or PCOS, has been rebranded as polyendocrine metabolic ovarian syndrome, or PMOS, to better reflect its complex nature. This change was driven by a global effort led by Professor Helena Teede, aiming to address misconceptions and improve patient care. The new name emphasizes the endocrine, metabolic, and ovarian effects, moving beyond the outdated focus on fertility and weight. This shift signals a move towards more comprehensive care, with full implementation in global guidelines by 2028. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/edeed7028d90a9cc